Table 2: The level of H. pylori resistance to clarithromycin (According recent Workshop of European Helicobacter Study) [37].

Country, number of patients (n)

Resistance to antibiotics, %

AMO

CLA

MTX

TETR

FTOR

RIF

FURAZ

Thailand [38], n = 400

5.2

3.7

3.6

1.7

7.7-CIPRO

7.2-LEVO

-

-

Laos [38], n = 119

-

1.6

-

-

13.4

-

-

Bhutan [38], n = 111

0

0

82.9

0

2.7

-

-

Myanmar [38], n = 52

0

0

36.5

0

5.8

-

-

Spain [39], n = 254

-

53.8

34.9

-

6.9-LEVO

-

-

Greece [40], n = 77

3.9

47.7

21.5

-

6.2-LEVO

-

-

Brasil [41], n = 72

-

12.5

-

-

11.1

-

-

Mongolia [42], n = 152

33

35

68.4

-

-

-

-

Iran [43], n = 58

27.21

30.37

81.64

42.4

-

-

-

Latin America [44]

4

12

53

6

15

-

3

New Zeeland [45]

-

16.4

49.3

0

9.5

-

-

Korea [46]

2.1

16

56.3

0

22.3

0

0

Korea [47]

14.9

23.7

-

-

28.4

-

-

Belgium [48]

0.8

13.3

26.1

-

23.8

-

-

Germany [49]

0

7.5

32.5

Менее 5

11.7

5

-

Ireland [50]

-

-

-

0

11.7

-

-

China [51]

0.1

21.5

95.4

-

20.6

0,1

-

De Francesco V et al. A systematic review of studies from many countries [52]

11.s2

17.2

26.7

5.9

16.2-LEVO

1,4

-

 

Comment to table 2: AMO amoxicillin, CLA clarithromycin, MTX methotrexate, TETRA tetracyclin, FTOR fluoroquinolone (CIP ciprofloxacin, LEVO levofloxacin), RIF rifabutin, FURAZ furazolidone.